Limiting dilution analysis of the B cell compartment in human bone marrow
- 1 January 1986
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 16 (2) , 139-145
- https://doi.org/10.1002/eji.1830160206
Abstract
Mononuclear cells (MNC) obtained from adult rib specimen were investigated for their capacity to produce immunoglobulin (Ig) in vitro. Using limiting dilution analysis 3 populations of B lineage cells could be distinguished. The first produces Ig in culture without any intentional activation. These cells are strictly nonproliferating and sustain extraordinary secretory rates of 5 × 107‐10 × 107 molecules IgG, IgA or IgM/cell/h for at least 2 weaks. They occur at frequencies of 1 × 10‐4‐10 × 10−4 (marrow MNC) or represent 1–5% of marrow B cells. Following exposure to infectious Epstein‐Barr virus (EBV), these cells do not (a) proliferate, (b) express EBV‐determined nuclear antigens (EBNA), (c) enhance their secretory rates or (d) show secretory activity for prolonged time. These cells are therefore EBV resistant. If these cells produced their antibody at similar rates in vivo, then their frequencies would suggest that they could provide up to 2/3 of daily synthetic rates for IgG and IgA and 20–30% of the daily IgM production. The second population of marrow B cells is exclusively committed to IgM production. Following exposure to EBV these cells proliferate, express EBNA and begin to secrete IgM. The third population represents 90% of marrow B cells. In our hands, these cells are unable to produce Ig in vitro.This publication has 23 references indexed in Scilit:
- Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune responseImmunology Today, 1984
- Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.Journal of Clinical Investigation, 1984
- SYNTHESIS AND SECRETION OF IgA, IgM, AND IgG BY PERIPHERAL BLOOD MONONUCLEAR CELLS IN HUMAN DISEASE STATES, BY ISOLATED HUMAN INTESTINAL MONONUCLEAR CELLS, AND BY HUMAN BONE MARROW MONONUCLEAR CELLS FROM RIBS*Annals of the New York Academy of Sciences, 1983
- Immunoglobulin production by tonsil lymphocytes before and after Epstein-Barr virus transformationCellular Immunology, 1982
- ‘Background’ immunoglobulin production: measurement, biological significance and regulationImmunology Today, 1982
- Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybridsCellular Immunology, 1982
- Epstein‐Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infectionEuropean Journal of Immunology, 1982
- A Live Human B‐Cell Activator Operating in Isolation of Other Cellular InfluencesScandinavian Journal of Immunology, 1979
- Inhibition of mitogenic stimulation of mouse lymphocytes by anti‐mouse immunoglobulin antibodies. I. Mode of actionEuropean Journal of Immunology, 1974
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973